ArticlePharmaceuticals (Basel, Switzerland)2024

Repurposing Osimertinib and Gedatolisib for Glioblastoma Treatment: Evidence of Synergistic Effects in an In Vitro Phenotypic Study.

Vitória Santório de São José et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.